Who owns UNICYCIVE THERAPEUTICS INC?

Tip: Access positions for across all investors

Analyze quarterly positions in Unicycive Therapeutics with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of Unicycive Therapeutics stock

Who bought or sold UNICYCIVE THERAPEUTICS INC this quarter?

Fund or Company Name Shares Held Valued At Change in Shares As Of Actions
RA Capital Management 3.5M $3.0M 0% Dec 2023
 View chart
Vivo Capital 3.5M $4.8M 0% Mar 2024
 View chart
Nantahala Capital Management 3.4M $3.0M -1% Dec 2023
 View chart
BVF 2.1M $1.8M -38% Dec 2023
 View chart
Rosalind Advisors 1.9M $2.6M 100% Mar 2024
 View chart
Vanguard Group 115k $100k 0% Dec 2023
 View chart
Goldman Sachs Group 93k $81k 0% Dec 2023
 View chart
Citadel Advisors 35k $31k 100% Dec 2023
 View chart
Captrust Financial Advisors 19k $16k 0% Dec 2023
 View chart
Tandem Capital Management Corp 16k $13k 0% Dec 2023
 View chart
Wells Fargo & Company 193.00 $167.002900 395% Dec 2023
 View chart
UBS Group 176.00 $152.996800 -75% Dec 2023
 View chart

Who sold out of Unicycive Therapeutics?

Fund or Company Name Date Sold Shares Held Valued At
Beacon Pointe Advisors Sep 2023 12k $10k
Two Sigma Securities Sep 2023 11k $9.6k
Virtu Financial Sep 2023 11k $9.0k